Corvus Pharmaceuticals, Inc. Common Stock (CRVS) Stock
NASDAQ · CRVS
12.42
Fundamentals
Market cap
$1.06B
Price / Earnings ratio
-19.5x
Price / Sales ratio
N/A
Price / Book ratio
4.7x
Return on assets
-0.4%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Corvus Pharmaceuticals, Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees37
CEODr. Richard A. Miller M.D.
IPO DateMar 23, 2016
HeadquartersSouth San Francisco, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Richard A. Miller M.D. | Co-Founder, President, CEO & Chairman of the Board | 1951 |
| Dr. Peter A. Thompson FACP, M.D. | Co-Founder & Independent Director | 1960 |
| Mr. Leiv Lea | Chief Financial Officer | 1954 |
| Dr. William Benton Jones Ph.D. | Senior Vice President of Pharmaceutical Development | 1966 |
| Mr. Jeffrey S. Arcara | Senior VP & Chief Business Officer | 1969 |
Fundamentals
Valuation
Market cap$1.06B
Price-to-sales ratioN/A
Price-to-book value4.69
Price-earnings ratio-19.50
Return on Equity-39.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratio0.00
Earnings Per Share
Earnings Per Share$-0.61
Income Statement
Average volume1,046,635
EBITDA$-44.06M
1 year high (52w)$26.95
1 year low (52w)$5.74
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



